| Primary |
| Hypercholesterolaemia |
27.7% |
| Hypertension |
12.7% |
| Hyperlipidaemia |
9.4% |
| Blood Cholesterol Increased |
6.9% |
| Type Iia Hyperlipidaemia |
5.3% |
| Dyslipidaemia |
4.3% |
| Coronary Artery Disease |
4.1% |
| Myocardial Infarction |
3.8% |
| Essential Hypertension |
3.6% |
| Angina Pectoris |
3.1% |
| Prophylaxis |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Alpha-1 Anti-trypsin Deficiency |
2.5% |
| Myocardial Ischaemia |
2.5% |
| Coronary Heart Disease |
1.8% |
| Acute Myocardial Infarction |
1.5% |
| Blood Triglycerides Increased |
1.5% |
| Pneumonia Bacterial |
1.5% |
| Dementia Alzheimer's Type |
1.0% |
| Diabetes Mellitus |
1.0% |
|
| Myalgia |
12.3% |
| Rhabdomyolysis |
7.7% |
| Muscle Atrophy |
6.9% |
| Transaminases Increased |
6.9% |
| Polyneuropathy |
6.2% |
| Muscle Spasms |
5.4% |
| Weight Decreased |
5.4% |
| Liver Injury |
4.6% |
| Tendonitis |
4.6% |
| Blood Creatine Phosphokinase Increased |
3.8% |
| Death |
3.8% |
| Hepatocellular Injury |
3.8% |
| Neuropathy Peripheral |
3.8% |
| Pain In Extremity |
3.8% |
| Skin Exfoliation |
3.8% |
| Tendon Rupture |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Gamma-glutamyltransferase Increased |
3.1% |
| Muscle Disorder |
3.1% |
| Myocardial Infarction |
3.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
20.3% |
| Hypercholesterolaemia |
12.0% |
| Hyperlipidaemia |
11.2% |
| Hypertension |
11.2% |
| Product Used For Unknown Indication |
7.0% |
| Essential Hypertension |
6.5% |
| Myocardial Infarction |
3.9% |
| Angina Pectoris |
3.1% |
| Coronary Artery Disease |
3.1% |
| Blood Cholesterol Increased |
2.9% |
| Coronary Heart Disease |
2.6% |
| Dyslipidaemia |
2.1% |
| Renal Impairment |
2.1% |
| Agitation |
1.8% |
| Depression |
1.8% |
| Diabetes Mellitus |
1.8% |
| Prophylaxis |
1.8% |
| Dementia Alzheimer's Type |
1.6% |
| Renal Disorder |
1.6% |
| Schizophrenia |
1.6% |
|
| Rash |
13.8% |
| Rhabdomyolysis |
11.5% |
| Muscle Atrophy |
9.2% |
| Gamma-glutamyltransferase Increased |
5.7% |
| Muscular Weakness |
5.7% |
| Myalgia |
5.7% |
| Drug Exposure During Pregnancy |
4.6% |
| International Normalised Ratio Increased |
4.6% |
| Myocardial Infarction |
4.6% |
| Haemolysis |
3.4% |
| Liver Injury |
3.4% |
| Mixed Liver Injury |
3.4% |
| Nephrotic Syndrome |
3.4% |
| Neuropathy Peripheral |
3.4% |
| Schizophrenia |
3.4% |
| Sleep Apnoea Syndrome |
3.4% |
| Tendonitis |
3.4% |
| Blood Triglycerides Increased |
2.3% |
| Convulsion |
2.3% |
| Dermatitis Allergic |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.9% |
| Hypertension |
14.5% |
| Drug Use For Unknown Indication |
13.4% |
| Rheumatoid Arthritis |
5.0% |
| Pain |
4.6% |
| Coronary Artery Disease |
3.9% |
| Diabetes Mellitus |
3.5% |
| Hyperlipidaemia |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Osteoporosis |
2.8% |
| Prophylaxis |
2.8% |
| Hypercholesterolaemia |
2.6% |
| Depression |
2.0% |
| Atrial Fibrillation |
1.9% |
| Essential Hypertension |
1.7% |
| Renal Transplant |
1.7% |
| Asthma |
1.6% |
| Acute Myocardial Infarction |
1.5% |
| Constipation |
1.4% |
| Multiple Myeloma |
1.4% |
|
| Vomiting |
9.8% |
| Renal Failure Chronic |
8.4% |
| Syncope |
6.3% |
| Hypertension |
5.6% |
| Hyponatraemia |
5.6% |
| Progressive Multifocal Leukoencephalopathy |
5.6% |
| Pyrexia |
5.6% |
| Renal Failure Acute |
5.6% |
| Hypotension |
4.9% |
| Pancreatitis |
4.9% |
| Myocardial Infarction |
4.2% |
| Nausea |
4.2% |
| Renal Failure |
4.2% |
| Weight Decreased |
4.2% |
| Femur Fracture |
3.5% |
| General Physical Health Deterioration |
3.5% |
| Gynaecomastia |
3.5% |
| Neutropenia |
3.5% |
| Restlessness |
3.5% |
| Toxic Epidermal Necrolysis |
3.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
16.4% |
| Hypertension |
14.5% |
| Myocardial Infarction |
14.5% |
| Depression |
10.9% |
| Hyperlipidaemia |
5.5% |
| Atrial Fibrillation |
3.6% |
| Bacterial Infection |
3.6% |
| Essential Hypertension |
3.6% |
| Hypercholesterolaemia |
3.6% |
| Hypoglycaemia |
3.6% |
| Type 2 Diabetes Mellitus |
3.6% |
| Acute Myocardial Infarction |
1.8% |
| Alopecia |
1.8% |
| Analgesic Therapy |
1.8% |
| Atrial Flutter |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Breast Cancer |
1.8% |
| Candidiasis |
1.8% |
| Cardiac Disorder |
1.8% |
| Cardiac Failure |
1.8% |
|
| Hypersensitivity |
10.0% |
| Liver Disorder |
10.0% |
| Myalgia |
10.0% |
| Transaminases Increased |
10.0% |
| Hepatic Function Abnormal |
5.0% |
| Hyperphosphataemia |
5.0% |
| Hyponatraemia |
5.0% |
| International Normalised Ratio Increased |
5.0% |
| Low Density Lipoprotein Increased |
5.0% |
| Lymphadenopathy |
5.0% |
| Muscle Spasms |
5.0% |
| Red Blood Cell Sedimentation Rate Increased |
5.0% |
| Syncope |
5.0% |
| Thrombocytopenia |
5.0% |
| Tremor |
5.0% |
| Type 2 Diabetes Mellitus |
5.0% |
|
